Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gene mutational pattern and expression level in 560 acute myeloid leukemia patients and their clinical relevance

Published:2017-08-22 Issue:1 Volume:15 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Zhu Yong-Mei,Wang Pan-Pan,Huang Jin-Yan,Chen Yun-Shuo,Chen Bing,Dai Yu-Jun,Yan Han,Hu Yi,Cheng Wen-Yan,Ma Ting-Ting,Chen Sai-Juan,Shen Yang

Funder

National Natural Science Foundation of China

National Clinical research Base construction Projects of Traditional Medicine

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-017-1279-4.pdf

Reference49 articles.

1. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002;100(13):4325–36.

2. Mrozek K, Marcucci G, Nicolet D, Maharry KS, Becker H, Whitman SP, et al. Prognostic significance of the European leukemia net standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia. J Clin Oncol. 2012;30(36):4515–23.

3. Döhner H, Gaidzik VI. Impact of genetic features on treatment decisions in AML. ASH Educ Progr Book. 2011;2011(1):36–42.

4. Perea G, Lasa A, Aventin A, Domingo A, Villamor N, Queipo de Llano MP, et al. Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. Leukemia. 2006;20(1):87–94.

5. Guerrasio A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E, et al. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. Leukemia. 2002;16(6):1176–81.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MECOM and BAALC gene expression profiles in Egyptian patients with acute myeloid leukemia by next generation sequencing;Alexandria Journal of Medicine;2024-09-11

2. Prognostic significance of GATA2 in patients with MDS/AML: a systematic review and meta-analysis;Annals of Hematology;2024-07-19

3. Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients;Annals of Hematology;2024-05-09

4. Clinical significance of WT1 in the evaluation of therapeutic effect and prognosis of non-M3 acute myeloid leukemia;Cancer Biology & Therapy;2023-11-30

5. Transcriptional Response to Standard AML Drugs Identifies Synergistic Combinations;International Journal of Molecular Sciences;2023-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3